INTERACTION OF A NEW DEPOLYMERIZED HOLOTHURIAN GLYCOSAMINOGLYCAN WITH PROTEINS IN HUMAN PLASMA

In a rat template bleeding model, depolymerized holothurian glycosaminoglycan (DHG) prolonged bleeding time at 30 mg/kg i.v. but unfractionated heparin (UFH) had the same effect at 1 mg/kg i.v., indicating that DHG is much less bleeding than UFH. To characterize this difference, we examined the affi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thrombosis research 1996-08, Vol.83 (3), p.253-264
Hauptverfasser: Minamiguchi, Kazuhisa, Nagase, Hideki, Kitazato, Keiko T, Kitazato, Kenji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 264
container_issue 3
container_start_page 253
container_title Thrombosis research
container_volume 83
creator Minamiguchi, Kazuhisa
Nagase, Hideki
Kitazato, Keiko T
Kitazato, Kenji
description In a rat template bleeding model, depolymerized holothurian glycosaminoglycan (DHG) prolonged bleeding time at 30 mg/kg i.v. but unfractionated heparin (UFH) had the same effect at 1 mg/kg i.v., indicating that DHG is much less bleeding than UFH. To characterize this difference, we examined the affinity of DHG for plasma proteins by means of a glycosaminoglycan-conjugated cellulofine column in comparison with that of UFH. The DHG column strongly bound factor V, factor IX, protein S, histidine-rich glycoprotein, platelet factor 4 (PF4), β-thromboglobulin, von Willebrand factor, fibronectin, and heparin cofactor II, but did not bind fibrinogen, prothrombin, factor VII, protein C, antithrombin III (ATIII), plasminogen or α 2-plasmin inhibitor. The profile of protein binding to the UFH column was almost the same as that of the DHG column except that ATIII showed affinity for UFH. One of the reasons why DHG caused much less bleeding than UFH is thus suggested to be the differences in their affinity for ATIII in plasma.
doi_str_mv 10.1016/0049-3848(96)00134-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78387933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>004938489600134X</els_id><sourcerecordid>78387933</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-aaa7459f4853df7ef0c67b948f519c43d1b36e0b3be64db97e0e24939d166d563</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhoMoOj_-gUKuRC-qyZImzY1QZrWBrhlbh5sXhn6kUNmsNpvgvzdlw0uvztd73sN5ALjE6A4jzO4RosIjAQ1uBLtFCBPqLQ7AAAdceEPKh4dg8Cc5AafWvjsRx8I_BsdBQBFlfADeZJpF03CUSZVC9QRDmEYv8DGaqGQ5jqbyNXqEsUpUFs-nMkzhc7IcqVk4lqnqU9d5kVkMJ1OVRTKdQZnCeD527UkSzsbhOTiq85U1F_t4BuZPUTaKvUQ9y1GYeCXx-cbL85xTX9Q08ElVc1OjkvFC0KD2sSgpqXBBmEEFKQyjVSG4QWZIBREVZqzyGTkD1zvfz6792hq70evGlma1yj9Mu7WaB8RhIcQJ6U5Ydq21nan1Z9es8-5HY6R7rLpnpntmWvSFw6oXbu1q778t1qb6W9pzdPOH3dy4J78b02lbNuajNFXTmXKjq7b5_8AvJCB-3Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78387933</pqid></control><display><type>article</type><title>INTERACTION OF A NEW DEPOLYMERIZED HOLOTHURIAN GLYCOSAMINOGLYCAN WITH PROTEINS IN HUMAN PLASMA</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Minamiguchi, Kazuhisa ; Nagase, Hideki ; Kitazato, Keiko T ; Kitazato, Kenji</creator><creatorcontrib>Minamiguchi, Kazuhisa ; Nagase, Hideki ; Kitazato, Keiko T ; Kitazato, Kenji</creatorcontrib><description>In a rat template bleeding model, depolymerized holothurian glycosaminoglycan (DHG) prolonged bleeding time at 30 mg/kg i.v. but unfractionated heparin (UFH) had the same effect at 1 mg/kg i.v., indicating that DHG is much less bleeding than UFH. To characterize this difference, we examined the affinity of DHG for plasma proteins by means of a glycosaminoglycan-conjugated cellulofine column in comparison with that of UFH. The DHG column strongly bound factor V, factor IX, protein S, histidine-rich glycoprotein, platelet factor 4 (PF4), β-thromboglobulin, von Willebrand factor, fibronectin, and heparin cofactor II, but did not bind fibrinogen, prothrombin, factor VII, protein C, antithrombin III (ATIII), plasminogen or α 2-plasmin inhibitor. The profile of protein binding to the UFH column was almost the same as that of the DHG column except that ATIII showed affinity for UFH. One of the reasons why DHG caused much less bleeding than UFH is thus suggested to be the differences in their affinity for ATIII in plasma.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/0049-3848(96)00134-X</identifier><identifier>PMID: 8840467</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Animals ; anticoagulant ; Bleeding Time ; Blood Proteins - metabolism ; depolymerized holothurian glycosaminoglycan ; glycosaminoglycan ; Glycosaminoglycans - metabolism ; Glycosaminoglycans - pharmacology ; Hemorrhage - metabolism ; Humans ; Protein Binding ; Rats</subject><ispartof>Thrombosis research, 1996-08, Vol.83 (3), p.253-264</ispartof><rights>1996 Elsevier Science Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-aaa7459f4853df7ef0c67b948f519c43d1b36e0b3be64db97e0e24939d166d563</citedby><cites>FETCH-LOGICAL-c357t-aaa7459f4853df7ef0c67b948f519c43d1b36e0b3be64db97e0e24939d166d563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0049-3848(96)00134-X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8840467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Minamiguchi, Kazuhisa</creatorcontrib><creatorcontrib>Nagase, Hideki</creatorcontrib><creatorcontrib>Kitazato, Keiko T</creatorcontrib><creatorcontrib>Kitazato, Kenji</creatorcontrib><title>INTERACTION OF A NEW DEPOLYMERIZED HOLOTHURIAN GLYCOSAMINOGLYCAN WITH PROTEINS IN HUMAN PLASMA</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>In a rat template bleeding model, depolymerized holothurian glycosaminoglycan (DHG) prolonged bleeding time at 30 mg/kg i.v. but unfractionated heparin (UFH) had the same effect at 1 mg/kg i.v., indicating that DHG is much less bleeding than UFH. To characterize this difference, we examined the affinity of DHG for plasma proteins by means of a glycosaminoglycan-conjugated cellulofine column in comparison with that of UFH. The DHG column strongly bound factor V, factor IX, protein S, histidine-rich glycoprotein, platelet factor 4 (PF4), β-thromboglobulin, von Willebrand factor, fibronectin, and heparin cofactor II, but did not bind fibrinogen, prothrombin, factor VII, protein C, antithrombin III (ATIII), plasminogen or α 2-plasmin inhibitor. The profile of protein binding to the UFH column was almost the same as that of the DHG column except that ATIII showed affinity for UFH. One of the reasons why DHG caused much less bleeding than UFH is thus suggested to be the differences in their affinity for ATIII in plasma.</description><subject>Animals</subject><subject>anticoagulant</subject><subject>Bleeding Time</subject><subject>Blood Proteins - metabolism</subject><subject>depolymerized holothurian glycosaminoglycan</subject><subject>glycosaminoglycan</subject><subject>Glycosaminoglycans - metabolism</subject><subject>Glycosaminoglycans - pharmacology</subject><subject>Hemorrhage - metabolism</subject><subject>Humans</subject><subject>Protein Binding</subject><subject>Rats</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF1LwzAUhoMoOj_-gUKuRC-qyZImzY1QZrWBrhlbh5sXhn6kUNmsNpvgvzdlw0uvztd73sN5ALjE6A4jzO4RosIjAQ1uBLtFCBPqLQ7AAAdceEPKh4dg8Cc5AafWvjsRx8I_BsdBQBFlfADeZJpF03CUSZVC9QRDmEYv8DGaqGQ5jqbyNXqEsUpUFs-nMkzhc7IcqVk4lqnqU9d5kVkMJ1OVRTKdQZnCeD527UkSzsbhOTiq85U1F_t4BuZPUTaKvUQ9y1GYeCXx-cbL85xTX9Q08ElVc1OjkvFC0KD2sSgpqXBBmEEFKQyjVSG4QWZIBREVZqzyGTkD1zvfz6792hq70evGlma1yj9Mu7WaB8RhIcQJ6U5Ydq21nan1Z9es8-5HY6R7rLpnpntmWvSFw6oXbu1q778t1qb6W9pzdPOH3dy4J78b02lbNuajNFXTmXKjq7b5_8AvJCB-3Q</recordid><startdate>19960801</startdate><enddate>19960801</enddate><creator>Minamiguchi, Kazuhisa</creator><creator>Nagase, Hideki</creator><creator>Kitazato, Keiko T</creator><creator>Kitazato, Kenji</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960801</creationdate><title>INTERACTION OF A NEW DEPOLYMERIZED HOLOTHURIAN GLYCOSAMINOGLYCAN WITH PROTEINS IN HUMAN PLASMA</title><author>Minamiguchi, Kazuhisa ; Nagase, Hideki ; Kitazato, Keiko T ; Kitazato, Kenji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-aaa7459f4853df7ef0c67b948f519c43d1b36e0b3be64db97e0e24939d166d563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>anticoagulant</topic><topic>Bleeding Time</topic><topic>Blood Proteins - metabolism</topic><topic>depolymerized holothurian glycosaminoglycan</topic><topic>glycosaminoglycan</topic><topic>Glycosaminoglycans - metabolism</topic><topic>Glycosaminoglycans - pharmacology</topic><topic>Hemorrhage - metabolism</topic><topic>Humans</topic><topic>Protein Binding</topic><topic>Rats</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Minamiguchi, Kazuhisa</creatorcontrib><creatorcontrib>Nagase, Hideki</creatorcontrib><creatorcontrib>Kitazato, Keiko T</creatorcontrib><creatorcontrib>Kitazato, Kenji</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Minamiguchi, Kazuhisa</au><au>Nagase, Hideki</au><au>Kitazato, Keiko T</au><au>Kitazato, Kenji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>INTERACTION OF A NEW DEPOLYMERIZED HOLOTHURIAN GLYCOSAMINOGLYCAN WITH PROTEINS IN HUMAN PLASMA</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>1996-08-01</date><risdate>1996</risdate><volume>83</volume><issue>3</issue><spage>253</spage><epage>264</epage><pages>253-264</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>In a rat template bleeding model, depolymerized holothurian glycosaminoglycan (DHG) prolonged bleeding time at 30 mg/kg i.v. but unfractionated heparin (UFH) had the same effect at 1 mg/kg i.v., indicating that DHG is much less bleeding than UFH. To characterize this difference, we examined the affinity of DHG for plasma proteins by means of a glycosaminoglycan-conjugated cellulofine column in comparison with that of UFH. The DHG column strongly bound factor V, factor IX, protein S, histidine-rich glycoprotein, platelet factor 4 (PF4), β-thromboglobulin, von Willebrand factor, fibronectin, and heparin cofactor II, but did not bind fibrinogen, prothrombin, factor VII, protein C, antithrombin III (ATIII), plasminogen or α 2-plasmin inhibitor. The profile of protein binding to the UFH column was almost the same as that of the DHG column except that ATIII showed affinity for UFH. One of the reasons why DHG caused much less bleeding than UFH is thus suggested to be the differences in their affinity for ATIII in plasma.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>8840467</pmid><doi>10.1016/0049-3848(96)00134-X</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0049-3848
ispartof Thrombosis research, 1996-08, Vol.83 (3), p.253-264
issn 0049-3848
1879-2472
language eng
recordid cdi_proquest_miscellaneous_78387933
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
anticoagulant
Bleeding Time
Blood Proteins - metabolism
depolymerized holothurian glycosaminoglycan
glycosaminoglycan
Glycosaminoglycans - metabolism
Glycosaminoglycans - pharmacology
Hemorrhage - metabolism
Humans
Protein Binding
Rats
title INTERACTION OF A NEW DEPOLYMERIZED HOLOTHURIAN GLYCOSAMINOGLYCAN WITH PROTEINS IN HUMAN PLASMA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T15%3A34%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=INTERACTION%20OF%20A%20NEW%20DEPOLYMERIZED%20HOLOTHURIAN%20GLYCOSAMINOGLYCAN%20WITH%20PROTEINS%20IN%20HUMAN%20PLASMA&rft.jtitle=Thrombosis%20research&rft.au=Minamiguchi,%20Kazuhisa&rft.date=1996-08-01&rft.volume=83&rft.issue=3&rft.spage=253&rft.epage=264&rft.pages=253-264&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/0049-3848(96)00134-X&rft_dat=%3Cproquest_cross%3E78387933%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78387933&rft_id=info:pmid/8840467&rft_els_id=004938489600134X&rfr_iscdi=true